The neurodegenerative disease sector is experiencing unprecedented transformation as pharmaceutical companies intensify their focus on Alzheimer’s disease research and development. With millions of patients worldwide affected by this progressive cognitive disorder, the Alzheimer’s Disease Drugs Market has become a cornerstone of modern healthcare investment and innovation strategies. Current Market Landscape and Revenue Streams The contemporary Read.